A comparative study of thymol and thymoquinone used as SphK1 inhibitors against NSCLC H1299 and A549 cell lines showed that both compounds remarkably inhibited SphK1 with the IC50 values of 35.52 μM and 53.68 μM, respectively. The gene discussed is SPHK1; the disease is non-small cell lung carcinoma.